Hospital

The investigators identified 4 prognostic factors with high predictive ability and supported by moderate to high strength evidence beyond what is already available for cardiovascular disease.

The 23-valent pneumococcal polysaccharide vaccine was most likely associated with a higher risk of immunological events for those who were immunocompromised, but the events were low.

The investigators found that perceived racism in everyday life was not associated with a higher risk of coronary heart disease—only racism in the 3 specific categories.

The model was designed to help improve health outcomes, improve access to care, and lower costs for gene therapy.

Early signs of psychosis may be used to predict the risk of developing a full psychosis spectrum disorder.

This breathing pattern is called resonant breathing and has been shown to improve heart rate variability.

Leg compression therapy was associated with decreased brain natriuretic peptide levels without any adverse events for patients with stable chronic heart failure.

In a study, more than 28% of participants met an ideal cardiovascular health score at the beginning of the study, with only 16% having ideal cardiovascular health at the 20-year mark.

The company seeks the approval for both the intravenous and subcutaneous administration routes.

Approximately 41% of enrolled patients responded to NX-2127, and the BTK degrader overcame resistance to nearly all BTK mutations that were identified to cause resistance.

According to the authors, the test has promise in guiding treatment but needs further refining to obtain information beyond molecular subtyping.

This approach may help prevent premature deaths attributed to preventable or treatable cardiovascular disease.

These heat-not-burn cigarettes are incorrectly assumed to be healthier than traditional tobacco cigarettes.

The diabetes/weight loss drug has surged in popularity, and new trials are evaluating it for certain pediatric patients.

There are 2 features of weight loss interventions which are most likely to improve weight loss outcomes—having access to professional health coaches and social support from other users.

The company will discontinue the development and commercialization of aducanumab-avwa (Aduhelm) for intravenous use and will terminate the ENVISION clinical study.

In December 2023, the FDA granted expanded indications for bempedoic acid and bempedoic acid plus ezetimibe in the treatment of primary hyperlipidemia.

The diabetes/weight loss drug is be evaluated in trials for pediatric patients who are at least 10 years of age.

Survival rates were similar between non-Hispanic African American and non-Hispanic White patients who received treatment, indicating a need to address barriers to multiple myeloma treatment and racial disparities.

Daratumumab and hyaluronidase-fihj in combination with other therapies was previously approved by the FDA in May 2020 for 8 indications in multiple myeloma.

However, different recommendations may actually be valuable, as different countries have different population-based needs.

Supplementation during pregnancy also reduced communication warning behaviors in children who developed autism compared to the children of women who did not take supplements.

Creating a free app to assist in vancomycin dosing proved to be an entertaining and enlightening journey.

Pharmacists can heighten awareness about cardiovascular health and promote heart-healthy lifestyles.

Older adults, patients with weakened immune systems, individuals living in long-term facilities, and those with underlying cardiopulmonary disease are at a higher risk of developing severe RSV infection outcomes.

Afami-cel had engineered t-cell receptor T-cells target MAGE-A4+ tumors, which are highly expressed in synovial sarcoma with HLA-A*02.

The findings suggest that further research on additional intervention methods and expanding access to hydroxyurea in Africa could benefit young patients with sickle cell disease.

A growing number of adult and pediatric patients are being diagnosed with type 2 diabetes, despite increases in care modalities.